ACCENDRA HEALTH INCACHEarnings & Financial Report
NYSE · Consumer Discretionary · Wholesale-Medical, Dental & Hospital Equipment & Supplies
Revenue
$660.4M
Gross Profit
$544.2M
Operating Profit
$16.9M
Net Profit
$-31.9M
Gross Margin
82.4%
Operating Margin
2.6%
Net Margin
-4.8%
YoY Growth
-74.2%
EPS
$-0.42
ACCENDRA HEALTH INC Q2 FY2024 Financial Summary
ACCENDRA HEALTH INC reported revenue of $660.4M (down 74.2% YoY) for Q2 FY2024, with a net profit of $-31.9M (down 13.0% YoY) (-4.8% margin). Cost of goods sold was $116.2M, operating expenses totaled $527.2M.
Key Financial Metrics
| Total Revenue | $660.4M |
|---|---|
| Net Profit | $-31.9M |
| Gross Margin | 82.4% |
| Operating Margin | 2.6% |
| Report Period | Q2 FY2024 |
ACCENDRA HEALTH INC Annual Revenue by Year
ACCENDRA HEALTH INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.8B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.8B |
| 2024 | $2.7B |
| 2023 | $2.6B |
| 2022 | $10.0B |
ACCENDRA HEALTH INC Quarterly Revenue & Net Profit History
ACCENDRA HEALTH INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $-1.2B | +2.4% | $-56.3M | 4.5% |
| Q3 FY2025 | $697.3M | +1.5% | $-150.3M | -21.6% |
| Q2 FY2025 | $681.9M | +3.3% | $-869.1M | -127.4% |
| Q1 FY2025 | $2.6B | +0.7% | $-25.0M | -0.9% |
| Q4 FY2024 | $-1.3B | +75.0% | $-296.1M | 23.1% |
| Q3 FY2024 | $686.8M | -73.5% | $-12.8M | -1.9% |
| Q2 FY2024 | $660.4M | -74.2% | $-31.9M | -4.8% |
| Q1 FY2024 | $2.6B | +3.6% | $-21.9M | -0.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.61B | $660.4M | $686.8M | $-1.28B | $2.63B | $681.9M | $697.3M | $-1.25B |
| YoY Growth | 3.6% | -74.2% | -73.5% | 75.0% | 0.7% | 3.3% | 1.5% | 2.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $5.21B | $5.30B | $5.08B | $4.66B | $4.86B | $4.15B | $4.04B | $2.45B |
| Liabilities | $4.31B | $4.44B | $4.21B | $4.07B | $4.29B | $4.44B | $4.47B | $2.91B |
| Equity | $916.0M | $881.8M | $895.7M | $586.4M | $571.0M | $-281.0M | $-429.5M | $-461.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-53.0M | $116.1M | $27.3M | $71.0M | $-35.1M | $37.6M | $-172.5M |